| RS1600416052 |
PNKP
|
Health Risk |
Pathogenic |
Microcephaly, seizures |
| RS1600423552 |
PNKP
|
Health Risk |
Likely pathogenic |
— |
| RS1600429244 |
MAFB
|
Health Risk |
Likely pathogenic |
Multicentric carpo-tarsal osteolysis with or without nephropathy, Multicentric carpo-tarsal osteolysis with or without nephropathy |
| RS1600429262 |
MAFB
|
Health Risk |
Pathogenic |
Multicentric carpo-tarsal osteolysis with or without nephropathy, Multicentric carpo-tarsal osteolysis with or without nephropathy |
| RS1600429281 |
MAFB
|
Health Risk |
Likely pathogenic |
Carpal osteolysis, Multicentric carpo-tarsal osteolysis with or without nephropathy |
| RS1600445482 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1600446366 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1600446408 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1600448065 |
MYH7B
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy 1 |
| RS1600462474 |
MYH7B
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy 1 |
| RS1600467547 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1600469027 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1600469287 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1600470099 |
LGI4
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 1, neurogenic |
| RS1600471396 |
CNOT3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS1600475941 |
DDRGK1
|
Health Risk |
Likely pathogenic |
— |
| RS1600477446 |
PANK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pigmentary pallidal degeneration, Hypoprebetalipoproteinemia |
| RS1600477808 |
MYH7B
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy 1 |
| RS1600480573 |
MYH7B
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy 1 |
| RS1600482167 |
PRKAR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Carney complex |
| RS1600482909 |
JPH2
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 17, Hypertrophic cardiomyopathy 17 |
| RS1600484162 |
PRKAR1A
|
Health Risk |
Likely pathogenic |
— |
| RS1600486197 |
PRKAR1A
|
Health Risk |
Likely pathogenic |
Acrodysostosis 1 with or without hormone resistance, Acrodysostosis 1 with or without hormone resistance |
| RS1600501018 |
CNOT3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS1600504088 |
CNOT3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS1600504872 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1600509558 |
ITPA
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 35 |
| RS1600514073 |
CNOT3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS1600534514 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1600542260 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1600542275 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1600546214 |
ARFGEF2
|
Health Risk |
Likely pathogenic |
— |
| RS1600548506 |
PANK2
|
Health Risk |
Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1600561475 |
SLC4A11
|
Health Risk |
Pathogenic/Likely pathogenic |
Corneal dystrophy, Fuchs endothelial |
| RS1600566207 |
PANK2
|
Health Risk |
Pathogenic |
— |
| RS1600577387 |
PROKR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 3 with or without anosmia, Hypogonadotropic hypogonadism 3 with or without anosmia |
| RS1600578193 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1600583334 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS1600586513 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1600586587 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Myelodysplastic syndrome |
| RS1600587608 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1600588199 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS1600588239 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS1600590580 |
SLC12A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 34 |
| RS1600592765 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1600592887 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS1600592990 |
ASXL1
|
Health Risk |
Likely pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS1600594932 |
ASXL1
|
Health Risk |
Pathogenic |
— |
| RS1600596180 |
NOVA2
|
Health Risk |
Pathogenic |
Severe intellectual disability, Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities |
| RS1600618680 |
SLC4A11
|
Health Risk |
Pathogenic |
Corneal dystrophy, Fuchs endothelial |
| RS1600621248 |
RPS19
|
Health Risk |
Conflicting classifications of pathogenicity |
Landsteiner-Wiener phenotype, Diamond-Blackfan anemia |
| RS1600623496 |
ARFGEF2
|
Health Risk |
Pathogenic |
Periventricular heterotopia with microcephaly, autosomal recessive |
| RS1600630942 |
RYR1
|
Health Risk |
Likely pathogenic |
Congenital multicore myopathy with external ophthalmoplegia, Congenital multicore myopathy with external ophthalmoplegia |
| RS1600631294 |
CD79A
|
Health Risk |
Pathogenic |
Inherited Immunodeficiency Diseases, Inherited Immunodeficiency Diseases |
| RS1600631593 |
CD79A
|
Health Risk |
Pathogenic |
Agammaglobulinemia 3, autosomal recessive |
| RS1600635111 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1600644179 |
SMARCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1600644640 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1600649879 |
RYR1
|
Health Risk |
Likely pathogenic |
Congenital multicore myopathy with external ophthalmoplegia, Congenital multicore myopathy with external ophthalmoplegia |
| RS1600650861 |
CRLF1
|
Health Risk |
Pathogenic |
Cold-induced sweating syndrome 1, Cold-induced sweating syndrome 1 |
| RS1600651228 |
CRLF1
|
Health Risk |
Pathogenic |
Crisponi/Cold-induced sweating syndrome, Crisponi/Cold-induced sweating syndrome |
| RS1600651595 |
MBOAT7
|
Health Risk |
Pathogenic |
— |
| RS1600656141 |
PIGU
|
Health Risk |
Pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 21, Glycosylphosphatidylinositol biosynthesis defect 21 |
| RS1600658150 |
CD40
|
Health Risk |
Likely pathogenic |
— |
| RS1600682739 |
RYR1
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita, Fetal akinesia deformation sequence 1 |
| RS1600683021 |
RYR1
|
Health Risk |
Pathogenic |
— |
| RS1600683731 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Cardiovascular phenotype |
| RS1600700389 |
NLRP12
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome, Autoinflammatory syndrome |
| RS1600704961 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Cardiovascular phenotype |
| RS1600706153 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related myopathy, RYR1-related myopathy |
| RS1600707958 |
HNF4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1600710669 |
HNF4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1600711065 |
LDLR
|
Health Risk |
Likely pathogenic |
— |
| RS1600713742 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1600714727 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial neonatal |
| RS1600715039 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS1600715089 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1600715567 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1600720232 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1600720921 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS1600726930 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS1600727285 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Dyslipidemia |
| RS1600727337 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS1600727715 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Cardiovascular phenotype |
| RS1600731073 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1600731198 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 1, Monogenic diabetes |
| RS1600731888 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1600732159 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1600732174 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1600732566 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1600732894 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS1600742966 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS1600743301 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS1600751236 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1600755429 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1600755440 |
KCNQ2
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS1600755607 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1600755957 |
HCK
|
Health Risk |
Likely pathogenic |
— |
| RS1600762098 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS1600765031 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |